Why the study?
SVC conduction delay or isolation has been observed during RSPV ablation using PFA due to anatomical proximity, but the long-term effects of PFA on the SVC remained unknown.
Does pulsed-field ablation for pulmonary vein isolation cause long-term superior vena cava impact in patients undergoing a second procedure?
Does pulsed-field ablation for pulmonary vein isolation cause long-term superior vena cava impact in patients undergoing a second procedure?
Pulsed-field ablation for right superior pulmonary vein isolation can cause durable, potentially arrhythmogenic low-voltage areas in the superior vena cava, particularly in patients with a short distance between these structures.
May signal unintended SVC effects during PFA; leaves open clinical relevance and need for mitigation in larger studies.
Background Superior vena cava (SVC) conduction delay or isolation during right superior pulmonary vein (RSPV) ablation using pulsed-field ablation (PFA) has previously been described because of the anatomical proximity of the SVC to the RSPV. Purpose We aimed to evaluate the long-term effects of PFA on the SVC. Methods Among 407 consecutive patients who underwent pulmonary vein isolation (PVI) with PFA (77, Varipulse; 150, PulseSelect; 180, FARAPULSE), 18 (median age: 66 years [range, 35–77 years]; eight females) underwent a second procedure (13 for recurrent atrial tachyarrhythmias, three for follow-up catheters prior to atrial septal defect occlusion, one for atrioventricular nodal reentrant tachycardia, and one for premature ventricular contraction). In the first procedure, three, seven, and eight patients were treated with Varipulse, PulseSelect, and FARAPULSE, respectively. Right atrial mapping was performed to evaluate the acute and chronic effects of PFA on the SVC. Results In the first procedure, a low-voltage area (<0.5 mV) of ≥0.5 cm2 newly appeared in the SVC following PFA in 14 of the 18 patients (77.8%) (2/3, Varipulse; 6/7, PulseSelect; 6/8, FARAPULSE). During the second procedure, conducted after a median follow-up of 155 days (interquartile range: 97–213 days), the SVC impact persisted in 8 (57.1%) of the 14 patients (1/3, Varipulse; 3/7, PulseSelect; 4/8, FARAPULSE) (Figure; left panel). The RSPV remained isolated in four (50.0%) of the eight patients who had residual SVC impact. The distance between the RSPV and SVC was significantly shorter in patients with residual SVC impact than in those without (3.4 ± 1.1 vs. 5.4 ± 2.2 mm, p=0.024). The newly emerged low-voltage area was associated with the isthmus of atrial tachycardia in one patient (12.5%) (Figure; right panel). Conclusion RSPV isolation with PFA can affect the SVC. This effect is durable in approximately 60% of patients and may be arrhythmogenic in some cases, especially in those with shorter RSPV to SVC distances.Figure
No takes yet. Share an insight, caveat, or question.
Kamakura et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: